Cargando…
WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
Autores principales: | Lotti, V., Merigo, F., Lagni, A., Di Clemente, A., Ligozzi, M., Bernardi, P., Rossini, G., Concia, E., Plebani, R., Romano, M., Sbarbati, A., Sorio, C., Gibellini, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184780/ http://dx.doi.org/10.1016/S1569-1993(22)00180-1 |
Ejemplares similares
-
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells
por: Lotti, Virginia, et al.
Publicado: (2022) -
439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
por: Sorio, C., et al.
Publicado: (2022) -
Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells
por: Merigo, Flavia, et al.
Publicado: (2022) -
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2
por: Lagni, Anna, et al.
Publicado: (2023) -
P05.04. Developing a dialogue between refugee patients and healthcare providers about traditional medicine use
por: Fenn, K, et al.
Publicado: (2012)